xenomics_purple.png
xenomics.jpg

LEADERSHIP

DAVID PREINER

Founder & CEO
JOHN HARROLD, PHD 

Co-Founder & COO
SOPHIE NI, PHD  

Co-Founder & CPO
RYAN HUBBARD, MD

Co-Founder & CMO

DAN KRIZNIC, CPA, CA

Co-Founder & CFO
NATASHA COLLINS, CPA, CA  

VP Finance

Imagine a better CRISPR. Xenomics is a biotechnology company that is advancing breakthroughs in genetics and biomanufacturing to combat major sustainability issues in food, energy, and health. At the heart of its technology is a next generation multi-site gene editing platform that enables biological advancement on an unparalleled scale. Xenomics combines genomics, synthetic biology, computational biology, and nanotechnology to advance the science needed to address humanity's most complex sustainability challenges—feeding, fueling, and healing society.

Exponential Genomics, Inc. -- Private -- Sector(s): BioTechnology -- Industry: Gene Technology